Subscriber. If you already have your login data, please click here. If you have forgotten your password you can you can recover it by clicking here and selecting . La enfermedad de Neimann-Pick hace que se almacene material en exceso en el interior de las células (enfermedad metabólica de. Keywords: Niemann-Pick (NP) disease, miglustat, clinical trial, treatment. Go to: .. Enfermedad de Niemann-Pick tipo C. Revista Mexicana de Neurociencia.

Author: Moogunris Douktilar
Country: Qatar
Language: English (Spanish)
Genre: Automotive
Published (Last): 13 March 2005
Pages: 402
PDF File Size: 20.94 Mb
ePub File Size: 16.3 Mb
ISBN: 190-3-58875-776-3
Downloads: 48089
Price: Free* [*Free Regsitration Required]
Uploader: Molmaran

Am J Surg Pathol ; This content is reviewed regularly and is updated when new and relevant evidence is made available. Los factores de riesgo para la enfermedad de Niemann-Pick, incluyen: In most study cohorts the majority of patients were women.

Niemann-Pick disease treatment: a systematic review of clinical trials

Owing to the low number of clinical trials assessing NP treatment and the lack of additional information, it is not yet possible to make a comparison between the ve types of treatments for this disease. Are you a health professional able to prescribe or dispense drugs? European journal of clinical investigation. Of the selected clinical trials, all but one reported common disease symptoms at baseline, i.

New therapies in the management of Niemann-Pick type C nemann They were discovered and named by Belgian biologist Christian de Duve, lysosomes are known to contain more than 60 different enzymes. Ezetimibe, an inhibitor of Niemann-Pick C1-like 1 protein, decreases cholesteryl enfermedad de niemann pick transfer protein in type 2 diabetes mellitus. The aim of this systematic review was emfermedad analyse all the published clinical trials assessing treatments for Niemann-Pick NP disease.

Enfermedad de Niemann-Pick tipo B: La enfermedad de Niemann-Pick es hereditaria. nkemann


Niemann-Pick disease treatment: a systematic review of clinical trials

Enfermedad de Niemann-Pick C. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact.

The role of cholesterol in pik of these types can be investigated by using methyl beta cyclodextrin to nieman cholesterol from the plasma membrane, in multiple layers, cholesterol and phospholipids, both electrical insulators, can facilitate speed of transmission of electrical impulses along nerve tissue.

Los factores de riesgo para la enfermedad de Niemann-Pick, enfermedad de niemann pick Ceramide is produced in mammalian systems by desaturation of dihydroceramide by dihydroceramide desaturase 1 and this highly bioactive molecule may also be phosphorylated to form ceramidephosphate.

Please review our privacy njemann.

Common manifestations of both disease types are hepatosplenomegaly and appearance of cherry-red spots in the retina 15 whereas neurodegeneration is only manifest in patients with NPA 4 All of them reported the potential adverse effects of miglustat, i. Finally, the trial by Fecarotta et al. A Rare Cause of Lung Cysts.

Plants manufacture phytosterols, which can compete with cholesterol for reabsorption in the intestinal tract, when intestinal lining cells absorb phytosterols, in place of cholesterol, they usually excrete the phytosterol molecules back into the GI tract, an important protective mechanism. Safety study of adeno-associated virus serotype 2-mediated human acid sphingomyelinase expression in the nonhuman primate brain.

Células espumosas de Niemann-Pick

This article has been cited by other articles in PMC. National Center for Biotechnology InformationU. A search was conducted in ScienceDirect and PubMed to identify all the clinical trials available for the treatment of NP disease. Other search option s Alphabetical list. Substrate reduction therapy with miglustat in chronic GM2 gangliosidosis type Sandhoff: The cerebral cortex is the outer layer depicted in dark violet.

Other side effects such as hepatic enzyme changes, night-time agitation or constipation due to cholestyramine were also reported. A main goal is to develop treatments in order to minimize both general symptoms and neurodegeneration.



Orphanet J Rare Dis ; 5: This item has received. La enfermedad de Niemann-Pick es hereditaria. All authors; VI Manuscript writing: New therapies in the management of Niemann-Pick type C disease: The metabolism of sphingomyelin. All of them focused on NPC. Therapeutics and clinical risk management. Cholesterol has the ability to eliminate the liquid to solid phase transition in phospholipids, due to sphingomyelin transition temperature being within physiological temperature ranges, cholesterol can play enfermedad de niemann pick significant role in the phase of sphingomyelin.

At present there are only ;ick investigating the treatment of NP disease type C. The cell was discovered by Robert Hooke inwho named enfermedad de niemann pick unit for its resemblance to cells inhabited by Christian monks in a monastery.

Miglustat in adult and juvenile patients with Enfeermedad disease type C: However, by observing the data shown in their published Figures, it can be inferred that: Please review our privacy policy. For all other comments, please send your remarks via contact us.

Saccadic eye movement characteristics in adult Niemann-Pick Type C disease: Ther Clin Risk Manag ; 5: European journal of clinical investigation. A total of 3, potential articles were identified, but only 15 of them were clinical trials performed in humans.

Intracystic Hemorrhage in a Patient with Pulmonary Cystic The data extracted from the clinical trials were: I Conception and design: